सेफाज़ोलिन के इंटरैक्शन

Hypersensitivity Reactions: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with beta-lactams. (इमिपेनेम और सिलास्टैटिन लेबल, चेतावनियां और सावधानियां)

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (एर्टापेनेम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Co-administration of probenecid with Cefazolin for Injection is not recommended. (सेफाज़ोलिन लेबल, दवाओं के इंटरैक्शन)

Co-administration of probenecid with Cefazolin for Injection is not recommended. (सेफाज़ोलिन लेबल, दवाओं के इंटरैक्शन)

Postmarketing reports suggest that concomitant administration of high doses of cefazolin and rifampin may prolong the prothrombin time, leading to severe vitamin K–dependent coagulation disorders that may be life-threatening or fatal. (रिफैम्पिसिन लेबल, चेतावनियां)

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (सेफाज़ोलिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Those at risk include patients with renal or hepatic impairment or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (एज़ट्रियोनम लेबल, चेतावनियां और सावधानियां)

Those at risk include patients with renal or hepatic impairment or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Ethacrynic acid may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics. (एथाक्रिनिक एसिड लेबल, दवाओं के इंटरैक्शन)

Those at risk include patients with renal or hepatic impairment or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Those at risk include patients with renal or hepatic impairment or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Increased nephrotoxicity has been reported following concomitant administration of aminoglycoside antibiotics and cephalosporins. (जेंटामाइसिन लेबल, दवाओं के इंटरैक्शन)

Those at risk include patients with renal or hepatic impairment or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Drug Interactions Protamine sulfate has been shown to be incompatible with certain antibiotics, including several of the cephalosporins and penicillins (see DOSAGE AND ADMINISTRATION ). (प्रोटामिन लेबल, सावधानियां)

Prothrombin time should be monitored in patients at risk and exogenous vitamin K administered as indicated (5.5) (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Those at risk include patients with renal or hepatic impairment or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Cephalosporin Furosemide can increase the risk of cephalosporin-induced nephrotoxicity even in the setting of minor or transient renal impairment. (फ्यूरोसेमाइड लेबल, दवाओं के इंटरैक्शन)

Those at risk include patients with renal or hepatic impairment or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Examples Cyclosporine A, trimethoprim/sulfamethoxazole, bile acid sequestrants (cholestyramine), rifampin as well as aminoglycoside, cephalosporin, fluoroquinolone and penicillin classes of antimicrobials Drugs Modulating Glucuronidation Clinical Impact Concomitant use with drugs inducing glucuronidation decreases MPA systemic exposure, potentially reducing mycophenolate… (माइकोफेनोलेट लेबल, दवाओं के इंटरैक्शन)

Those at risk include patients with renal or hepatic impairment or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Those at risk include patients with renal or hepatic impairment or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Prothrombin time should be monitored in patients at risk and exogenous vitamin K administered as indicated (5.5) (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Those at risk include patients with renal or hepatic impairment or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Some drugs (e.g., cefazolin, cephalothin), however, may interfere with certain HPLC techniques. (एमिनोफाइलिन लेबल, दवाओं के इंटरैक्शन)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Some drugs (e.g. cefazolin, cephalothin), however, may interfere with certain HPLC techniques. (थियोफाइलिन लेबल, दवाओं के इंटरैक्शन)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Before initiating therapy with Meropenem for injection, it is important to inquire about previous hypersensitivity reactions to penicillins, cephalosporins, other β-lactams, and other allergens. (मेरोपेनेम लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)

Anticonvulsant therapy should be continued in patients with known seizure disorders. (सेफाज़ोलिन लेबल, चेतावनियां और सावधानियां)